| P50 | author | Richard G Hegele | Q90437303 |
| P2093 | author name string | Peter Mastrangelo | |
| P2860 | cites work | A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease | Q21560951 |
| | Respiratory syncytial virus (RSV) infects neuronal cells and processes that innervate the lung by a process involving RSV G protein | Q24535536 |
| | Design and Characterization of Epitope-Scaffold Immunogens That Present the Motavizumab Epitope from Respiratory Syncytial Virus | Q27667750 |
| | Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes | Q27668015 |
| | Identification of nucleolin as a cellular receptor for human respiratory syncytial virus | Q28245563 |
| | The interactome of the human respiratory syncytial virus NS1 protein highlights multiple effects on host cell biology | Q28728377 |
| | Respiratory syncytial virus induces host RNA stress granules to facilitate viral replication | Q30156026 |
| | Human respiratory syncytial virus glycoproteins are not required for apical targeting and release from polarized epithelial cells | Q30440160 |
| | Ultrastructural analysis of the interaction between F-actin and respiratory syncytial virus during virus assembly | Q33297942 |
| | Molecular dissection of nucleolin's role in growth and cell proliferation: new insights | Q33764019 |
| | Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization | Q33784401 |
| | Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type | Q33980633 |
| | Toll-like receptor 4-mediated activation of p38 mitogen-activated protein kinase is a determinant of respiratory virus entry and tropism | Q34190714 |
| | Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine | Q34206177 |
| | Productive infection of isolated human alveolar macrophages by respiratory syncytial virus | Q34255436 |
| | Respiratory syncytial virus assembles into structured filamentous virion particles independently of host cytoskeleton and related proteins | Q34342428 |
| | Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology | Q34364942 |
| | High rates of detection of respiratory viruses in tonsillar tissues from children with chronic adenotonsillar disease | Q34369301 |
| | A systems-based approach to analyse the host response in murine lung macrophages challenged with respiratory syncytial virus | Q34626385 |
| | Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice | Q35188476 |
| | Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years | Q35566601 |
| | Cholesterol-rich lipid rafts are required for release of infectious human respiratory syncytial virus particles | Q35645249 |
| | Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern | Q35859950 |
| | Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics | Q36174346 |
| | Initiation and maintenance of persistent infection by respiratory syncytial virus | Q36525091 |
| | Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis. | Q36727270 |
| | Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection | Q36747814 |
| | The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes | Q36994686 |
| | Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease | Q37144420 |
| | A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction | Q37157161 |
| | Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6. | Q45774276 |
| | Production of acute bronchiolitis in guinea-pigs by human respiratory syncytial virus | Q45776801 |
| | Persistence of respiratory syncytial virus genome and protein after acute bronchiolitis in guinea pigs | Q45778176 |
| | The Development of Respiratory Syncytial Virus-Specific IgE and the Release of Histamine in Nasopharyngeal Secretions after Infection | Q45805502 |
| | Respiratory syncytial virus infection in immunosuppressed animals: implications in human infection | Q45828591 |
| | In vivo and in vitro studies on the use of the guinea pig as a model for virus-provoked airway hyperreactivity | Q45838335 |
| | Two distinct subtypes of human respiratory syncytial virus | Q45848624 |
| | Functional genetic variation in NFKBIA and susceptibility to childhood asthma, bronchiolitis, and bronchopulmonary dysplasia | Q46580246 |
| | CpG-oligodeoxynucleotides inhibit RSV-enhanced allergic sensitisation in guinea pigs | Q47856322 |
| | A linearized constraint-based approach for modeling signaling networks. | Q51432113 |
| | Relationship of early childhood viral exposures to respiratory symptoms, onset of possible asthma and atopy in high risk children: the Canadian Asthma Primary Prevention Study. | Q54560701 |
| | Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. | Q55053023 |
| | Respiratory syncytial virus vaccine development | Q56481283 |
| | Recovery of cytopathogenic agent from chimpanzees with coryza | Q74223084 |
| | The relationship between bronchiolitis and childhood asthma; a follow-up study of 100 cases of bronchiolitis | Q78515193 |
| | Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA | Q80146633 |
| | Respiratory syncytial virus persistence: evidence in the mouse model. | Q37280556 |
| | Respiratory syncytial virus glycoproteins uptake occurs through clathrin-mediated endocytosis in a human epithelial cell line | Q37307962 |
| | TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease | Q37364154 |
| | Pharmacotherapy of respiratory syncytial virus infection | Q37759642 |
| | The role of cytokines and chemokines in severe respiratory syncytial virus infection and subsequent asthma | Q37805072 |
| | Part 4. Interaction between air pollution and respiratory viruses: time-series study of daily mortality and hospital admissions in Hong Kong | Q37858951 |
| | Benefit and harm from immunity to respiratory syncytial virus: implications for treatment | Q38053916 |
| | The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development. | Q38068469 |
| | Predictive methods in drug repurposing: gold mine or just a bigger haystack? | Q38070040 |
| | Th17 lymphocytes in respiratory syncytial virus infection. | Q38086713 |
| | The histopathology of fatal untreated human respiratory syncytial virus infection | Q38435017 |
| | Multiple functional domains and complexes of the two nonstructural proteins of human respiratory syncytial virus contribute to interferon suppression and cellular location | Q38749026 |
| | Characterization of the interaction between human respiratory syncytial virus and the cell cycle in continuous cell culture and primary human airway epithelial cells | Q38749301 |
| | Cytokine profiles, signalling pathways and effects of fluticasone propionate in respiratory syncytial virus-infected human foetal lung fibroblasts | Q39200193 |
| | G protein variation in respiratory syncytial virus group A does not correlate with clinical severity | Q39461811 |
| | Development of allergy in children. I. Association with virus infections | Q39538238 |
| | Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene | Q39603697 |
| | Neutralization of respiratory syncytial virus after cell attachment. | Q39868901 |
| | Enhanced isolation of respiratory syncytial virus in cell culture | Q40647266 |
| | Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus | Q40732224 |
| | Distinct patterns of T- and B-cell immunity to respiratory syncytial virus induced by individual viral proteins | Q41092112 |
| | Variation in severity of respiratory syncytial virus infections with subtype | Q41194455 |
| | Internalization of anti-nucleolin antibody into viable HEp-2 cells | Q41242531 |
| | Repeated antigen challenge induces airway hyperresponsiveness with tissue eosinophilia in guinea pigs | Q41272725 |
| | Evaluation of Measles Vaccine Virus as a Vector to Deliver Respiratory Syncytial Virus Fusion Protein or Epstein-Barr Virus Glycoprotein gp350. | Q41557807 |
| | Respiratory syncytial virus infection in infants and correlation with meteorological factors and air pollutants | Q42279123 |
| | Formation of a stable mimic of ambient particulate matter containing viable infectious respiratory syncytial virus and its dry-deposition directly onto cell cultures | Q42284130 |
| | Intrinsic phenotypic differences of asthmatic epithelium and its inflammatory responses to respiratory syncytial virus and air pollution | Q42489442 |
| | The fusion glycoproteins of human respiratory syncytial virus of subgroups A and B: sequence conservation provides a structural basis for antigenic relatedness | Q43612954 |
| | Respiratory syncytial virus and asthma: still no final answer | Q43805248 |
| | Ozone effect on respiratory syncytial virus infectivity and cytokine production by human alveolar macrophages | Q43983226 |
| | Human respiratory syncytial virus viroporin SH: a viral recognition pathway used by the host to signal inflammasome activation | Q45353531 |
| | Role of human TLR4 in respiratory syncytial virus-induced NF-κB activation, viral entry and replication | Q45358034 |
| | Different NF-κB activation characteristics of human respiratory syncytial virus subgroups A and B. | Q45360702 |
| | Respiratory syncytial virus decreases p53 protein to prolong survival of airway epithelial cells. | Q45401032 |
| | T helper 1 background protects against airway hyperresponsiveness and inflammation in guinea pigs with persistent respiratory syncytial virus infection | Q45405429 |
| | Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection | Q45410833 |
| | The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease. | Q45417025 |
| | Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells | Q45423182 |
| | Latency and persistence of respiratory syncytial virus despite T cell immunity | Q45697249 |
| | Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiologic aspects of infection in infants and young children. | Q45719599 |
| | Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization. | Q45719601 |
| | Interaction between respiratory syncytial virus and particulate matter in guinea pig alveolar macrophages | Q45723494 |
| | Effects of respiratory syncytial virus persistence on airway responsiveness and inflammation in guinea-pigs | Q45745743 |
| | Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years | Q45747463 |
| | Effect of respiratory syncytial virus on subsequent allergic sensitization to ovalbumin in guinea-pigs | Q45748284 |
| | Persistence of respiratory syncytial virus (RSV) infection and development of RSV-specific IgG1 response in a guinea-pig model of acute bronchiolitis | Q45764708 |
| P433 | issue | 3 | |
| P304 | page(s) | 149-157 | |
| P577 | publication date | 2013-05-15 | |
| P1433 | published in | Current pediatrics reports | Q27724637 |
| P1476 | title | Host and Viral Factors in Respiratory Syncytial Virus Infection | |
| P478 | volume | 1 | |